ARS Pharmaceuticals, Inc. (SPRY) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

The next meaningful technical decision is likely to occur between support at 7.37 and resistance at 8.51. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant.

📊 Technical Summary

The latest close for ARS Pharmaceuticals, Inc. (SPRY) came in at 8.26 (+5.36%). The chart is still trading below both the 50-day and 200-day moving averages, leaving the overall technical backdrop under pressure for now. 20-day momentum is positive at +1.85%, with price is trading in the lower part of its roughly 52-week range (6.73–18.35), while ATR14 volatility is elevated at roughly 5.04% of price. RSI(14) is 50.9, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains above its signal line, which keeps the momentum structure biased to the upside. The MACD histogram is positive and expanding, pointing to improving upside momentum. Near-term structure is defined by support at 7.37 and resistance at 8.51. A clean break above resistance would strengthen the chart, while a loss of support would put the current setup under pressure. Fundamentals snapshot: Revenue: 32.50M · Net income: -171.30M · EPS (basic): -0.52. The interactive chart adds overlays, pattern context and a fuller structure view for deeper review.

Explore more